Nerve Grafting Technique to Preserve Erectile Function in Patients Undergoing Robotic Assisted Radical Prostatectomy

The investigator proposing a single arm prospective pilot trial evaluating the safety and the 1-year erectile recovery outcomes of patients undergoing Nerve Restoring (NR) Robotically assisted laparoscopic radical prostatectomy (RALP). During this study a total of 10 patients who are undergoing robotic prostatectomy will have their surgery performed utilizing a novel technique, NR-RALP, which incorporates a genitofemoral (GFN) nerve graft designed to try to improve the erectile function and recovery of men undergoing standard of care robotic prostatectomy while minimizing additional morbidity

Trial Details

NCT ID
NCT06521710
Phase
NA
Sponsor
Sir Mortimer B. Davis - Jewish General Hospital
Status
RECRUITING
Cancer Type
Prostate Cancer
Interventions
  • Intraoperative Somatic-Autonomic Nerve Grafting
Locations (sample)
  • Montreal, Quebec, Canada|45.50884,-73.58781
  • Montreal, Quebec, Canada|45.50884,-73.58781

Key Eligibility Criteria

  • Patients undergoing standard of care robotic radical prostatectomy for high-risk localized prostate cancer as defined by any of:
  • Gleason grade ≥8
  • \>pT2 on preoperative MRI imaging
  • Patients must have preoperative erectile function with a baseline IIEF score of ≥17

For full eligibility, visit ClinicalTrials.gov.

Check If You May Be Eligible

Trialify translates complex eligibility criteria into plain yes-or-no questions to help you understand if this trial might be right for you.

Find Prostate Cancer Trials on Trialify →